Citius Oncology, Inc. CTOR Financing Cash Flow
Financing Cash Flow at other companies
Other financials
Where this comes from
Reported directly by Citius Oncology, Inc. in its filing.
Tagged under the XBRL concept us-gaap:NetCashProvidedByUsedInFinancingActivities.
The official record: Citius Oncology, Inc.’s 10-Q, filed February 13, 2026, on SEC EDGAR. View the filing →
Ask your AI about Citius Oncology, Inc.'s financing cash flow.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI

Claude
Questions, answered.
- What is Citius Oncology, Inc.'s financing cash flow?
- Citius Oncology, Inc. (CTOR) reported financing cash flow of $15.13M in Q4 2025.
- How has Citius Oncology, Inc.'s financing cash flow changed year-over-year?
- Citius Oncology, Inc.'s financing cash flow increased by 298.9% year-over-year, from $3.79M to $15.13M.
- What does financing cash flow mean?
- Total net cash provided by or used in financing activities — debt issuance/repayment, equity transactions, and dividend payments.